Date(s) - 15 Sep 2015
4:00 pm - 5:00 pm
(Note: This webinar is being held from 4-5pm UK time, 11am-midday Eastern, 8-9am Pacific, 5-6pm CET.)
A “Pistoia Alliance Debates” webinar
Analytics has seen an explosion of interest over the last 5 years with the advanced and predictive analytics market projected to grow from $2.2B from 2013 to £3.4B by 2018 (IDC).
R&D groups in pharma are making significant investments in order to increase their ‘analytics’ capability; structured and unstructured data, big-data management, static and live data analytics, predictive analytics, Business Intelligence and analytics modelling.
We are only now starting to understand how data analytics will change the life science industry; from new target discovery through to novel application for existing drugs and therapies. We’d like to explore a number of topics with our Pistoia friends about their analytics experiences, share some use cases and examples.
What is the role of analytics in Lifescience and R&D? How is Pharma R&D making use of analytics? What are the key challenges R&D is wanting analytics to solve? What are the blockers; in-house skills? Investment? C-Suite awareness? What are the best practices and real-world application of an R&D analytics investment and solution? How is R&D working with suppliers and partners on their analytics endeavours?
This webinar will be chaired by Matthew Jones of Tessella and features Simon Thornber (GSK) and Eduardo Gonzalez (PerkinElmer).
Please register today for this free “Pistoia Alliance Debates” webinar on analytics in R&D.